Quoin Pharmaceuticals, Ltd. American Depositary Shares
QNRXStock
$4.16−53.48%52W
Market Cap$8.53M
P/E—
Div yield—
Beta1.48
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-78.84%
Price vs S&P 500 (4W)-6.20%
VGM Score20.77
Market Capitalization$8.53M
Earnings Surprise History
Q1 26-1.77est. -1.97
Analyst Recommendations
Apr 2026
May 2026
Jun 2026
Jul 2026
4.13
4.13
4.11
4.10
Industry Peers — Pharmaceuticals(563)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
QNRXQuoin Pharmaceuticals, Ltd. American Depositary Shares | — | — | D | $4.16 |
| LLYEli Lilly & Co. | D | B | B | $1169.17 |
| JNJJohnson & Johnson | D | C | B | $249.97 |
| ABBVABBVIE INC. | D | C | B | $254.39 |
| MRKMerck & Co., Inc. | C | C | B | $127.63 |
| NVSNovartis AG | C | C | C | $152.73 |
| NVONovo-Nordisk A/S | C | B | C | $51.48 |
| AZNAstraZeneca PLC | C | B | C | $169.29 |
| ABTAbbott Laboratories | C | C | D | $98.83 |
| PFEPfizer Inc. | B | C | C | $25.14 |
| VRTXVertex Pharmaceuticals Inc | D | C | C | $486.03 |
About
Quoin Pharmaceuticals is a clinical-stage specialty pharmaceutical company developing treatments for rare and orphan diseases. The company's pipeline of three products targets multiple indications including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, and Epidermolysis Bullosa.